PLx Pharma Inc.

PLx Pharma Inc.verified

PLXP

Price:

$0.087

Market Cap:

$2.53M

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-03-13

Stock Exchange

NASDAQ

Ticker

PLXP

The PE Ratio as of April 2024 (TTM) for PLx Pharma Inc. (PLXP) is -0.22

According to PLx Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -119.21% compared to the average of 1.16 of the last 4 quarters.

PLx Pharma Inc. (PLXP) Historical PE Ratio (quarterly & annually)

How has PLXP PE Ratio performed in the past?

The mean historical PE Ratio of PLx Pharma Inc. over the last ten years is -5.74. The current -0.22 PE Ratio has changed 288.88% with respect to the historical average. Over the past ten years (40 quarters), PLXP's PE Ratio was at its highest in in the December 2021 quarter at 15.48. The PE Ratio was at its lowest in in the June 2013 quarter at -42.81.

Quarterly (TTM)
Annual

Average

-5.74

Median

-3.62

Minimum

-30.88

Maximum

14.90

PLx Pharma Inc. (PLXP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PLx Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 305.72%

Maximum Annual PE Ratio = 14.90

Minimum Annual Increase = -572.27%

Minimum Annual PE Ratio = -30.88

Quarterly (TTM)
Annual
YearPE RatioChange
2021-3.683.68%
2020-3.5594.46%
2019-1.83-112.25%
201814.90-572.27%
2017-3.16305.72%
2016-0.78-86.20%
2015-5.64-14.35%
2014-6.58-59.31%
2013-16.17-47.63%

PLx Pharma Inc. (PLXP) Average PE Ratio

How has PLXP PE Ratio performed in the past?

The current PE Ratio of PLx Pharma Inc. (PLXP) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.02

5-year avg

0.54

10-year avg

-5.74

PLx Pharma Inc. (PLXP) PE Ratio vs. Peers

How is PLXP’s PE Ratio compared to its peers?

PLx Pharma Inc.’s PE Ratio is less than Biofrontera Inc. (-0.17), less than Guardion Health Sciences, Inc. (4.67), greater than Shuttle Pharmaceuticals Holdings, Inc. (-1.19), less than Akanda Corp. (-0.02), greater than China Pharma Holdings, Inc. (-0.71), less than Cann American Corp. (0.24), less than Acorda Therapeutics, Inc. (-0.00), greater than Kala Pharmaceuticals, Inc. (-0.38), less than Mallinckrodt plc (-0.00), less than Halo Collective Inc. (-0.00), greater than Alimera Sciences, Inc. (-8.12), greater than China SXT Pharmaceuticals, Inc. (-0.61), less than Petros Pharmaceuticals, Inc. (-0.01), greater than Societal CDMO, Inc. (-8.69), less than Organogenesis Holdings Inc. (22.49), greater than Lifecore Biomedical, Inc. (-2.93), greater than OptiNose, Inc. (-3.36),

Build a custom stock screener for PLx Pharma Inc. (PLXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PLx Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PLx Pharma Inc. (PLXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PLx Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is PLx Pharma Inc.'s PE Ratio?

How is the PE Ratio calculated for PLx Pharma Inc. (PLXP)?

What is the highest PE Ratio for PLx Pharma Inc. (PLXP)?

What is the 3-year average PE Ratio for PLx Pharma Inc. (PLXP)?

What is the 5-year average PE Ratio for PLx Pharma Inc. (PLXP)?

How does the current PE Ratio for PLx Pharma Inc. (PLXP) compare to its historical average?